ATHENEX - CHINA API BUSINESS
Athenex - China API Business engages in Active Pharmaceutical Ingredient (API) manufacturing operations.
Similar Organizations
Aun herbal remedies
Aun Herbal Remedies is a reputated Unani and Ayurvedic manufacturing & Herbal products
Libra Group
Libra Group is a pharmaceutical and medicine manufacturing company.
Saraca Laboratories
Saraca Laboratories is a pharmaceutical ingredients manufacturer.
More informations about "Athenex - China API Business"
Athenex Announces Closing of the Sale of its China API Business
BUFFALO, N.Y., Nov. 21, 2022 (GLOBE NEWSWIRE) -- Athenex, Inc., (NASDAQ: ATNX), a global biopharmaceutical company dedicated to the discovery, development, and … See details»
Athenex Announces Closing of the Sale of its China API
Nov 21, 2022 Athenex also entered into a long-term supply agreement with entities controlled by Chongqing Comfort for the supply of APIs needed for Athenex’s small molecule drug products. … See details»
Athenex - China API Business - Crunchbase Company Profile
Jul 11, 2022 Athenex - China API Business engages in Active Pharmaceutical Ingredient (API) manufacturing operations. Lists Featuring This Company ... 3,168 Number of Organizations • … See details»
Athenex - China API Business - Drug pipelines, Patents, Clinical …
Last update 19 Sep 2024. Athenex - China API Business. Private Company See details»
Athenex Announces Closing of the Sale of its China API Business
About Athenex, Inc. Founded in 2003, Athenex, Inc. is a global clinical-stage biopharmaceutical company dedicated to becoming a leader in the discovery, development, and … See details»
Athenex - China API Business - Products, Competitors, Financials ...
Athenex (NASDAQ: ATNX), formerly Kinex Pharmaceuticals, is a global oncology pharmaceutical company focused on the development and commercialization of next generation therapies for … See details»
Athenex Announces Entry into Agreement to Sell its China API …
Jul 11, 2022 Athenex, Inc. Expected sale proceeds of approximately $19.0 million. Company continues to monetize non-core assets to extend cash runway. Proceeds from the deal will be … See details»
Athenex unloads stake in Chinese API production business for …
Jul 12, 2022 Athenex API China Facilities Struggling biotech Athenex unloaded all of its equity interests in its Chinese subsidiaries that produce APIs as part of a $19 million deal with TiHe … See details»
Athenex Announces Entry into Agreement to Sell its China
Jul 11, 2022 Athenex Announces Entry into Agreement to Sell its China API Business to TiHe Capital (Bejing) Co., Ltd. July 11, 2022 08:00 ET | Source: Athenex, Inc. Athenex, Inc. See details»
Athenex Announces Closing of the Sale of its China API Business
BUFFALO, N.Y., Nov. 21, 2022 (GLOBE NEWSWIRE) -- Athenex, Inc. (ATNX), (NASDAQ: ATNX), a global biopharmaceutical company dedicated to the discovery, development, and … See details»
Athenex Announces Entry into Agreement to Sell its China API …
Jul 11, 2022 Athenex (NASDAQ: ATNX) announced plans to sell its China subsidiaries involved in Active Pharmaceutical Ingredient manufacturing to TiHe Capital for approximately $19 … See details»
Athenex Announces Entry into Agreement to Sell its China API …
BUFFALO, N.Y., July 11, 2022 (GLOBE NEWSWIRE) -- Athenex, Inc., (NASDAQ: ATNX), a global biopharmaceutical company dedicated to the discovery, development, and … See details»
Athenex - China API Business acquired by TiHe Capital - Crunchbase
TiHe Capital acquires Athenex - China API Business on 2022-07-11 for an undisclosed amount. New. Resources. Advanced Search. Start Free Trial . Talk With Sales ... Summary. Overview. … See details»
1.24亿元！纳斯达克上市公司Athenex出售中国原料药工厂医药新 …
2022年7月11日，美国纳斯达克上市公司Athenex发布公告， Athe nex及其附属公司已经达成协议，将其位于中国的API原料药工厂，以1.244亿元人民币（或1900万美元）的价格，出售给 泰 … See details»
Athenex Announces Closing of the Sale of its China API Business
Nov 22, 2022 Athenex Announces Closing of the Sale of its China API Business Hits:501 Date: 11/22/2022 BUFFALO, N.Y., Nov. 21, 2022 (GLOBE NEWSWIRE) -- Athenex, Inc., … See details»
Athenex voluntarily suspends production at its Chongqing, China, …
Jun 6, 2019 New York-based biotech Athenex has voluntarily suspended production at its Chongqing, China, API facility in the wake of explosions earlier this year at chemical plants in … See details»
China’s MiniMax debuts M1 model it says cost 200x less to
2 days ago Chinese AI company MiniMax has released a new AI model called M1 that it says equals the performance of top models from labs such as OpenAI, Anthropic, and Google … See details»
Athenex Announces Closing of the Sale of its China API Business
Nov 21, 2022 Athenex Announces Closing of the Sale of its China API Business GlobeNewswire November 21, 2022 BUFFALO, N.Y., Nov. 21, 2022 (GLOBE NEWSWIRE) -- Athenex, Inc., … See details»
Athenex Announces Entry into Agreement to Sell its China API …
Proceeds from the transaction will be used in part toward repaying existing debt and operating the business. The deal is subject to customary closing conditions, including obtaining certain … See details»
Athenex Announces Closing of the Sale of Its China API Business
Nov 21, 2022 Athenex, Inc., (NASDAQ: ATNX), a global biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies for the treatment of … See details»